发明名称 ANTI-IGE VACCINE
摘要 <P>PROBLEM TO BE SOLVED: To provide methods and compositions for treatment of IgE-mediated allergic disorders comprising an immunogenic amount of one or more antigenic peptides derived from CH3 domain or junction of CH3/CH4 domain of an IgE molecule, and to provide methods for the evaluation of IgE-mediated allergies in dogs. <P>SOLUTION: The invention relates to compositions comprising at least one antigenic peptide derived from the CH3 domain or CH3-CH4 domain junction of an IgE molecule coupled to a heterologous carrier protein. The compositions induce anti-IgE antibodies, which bind to soluble IgE in serum and other bodily fluids, but do not cross-link with receptor-bound IgE. The invention relates to methods for administering compositions to animals, preferably mammals and most preferably humans, for the treatment or prevention of IgE-mediated allergic disorders and methods for evaluating vaccines and other therapies for the treating IgE-mediated allergic disorders. <P>COPYRIGHT: (C)2012,JPO&INPIT
申请公布号 JP2012161322(A) 申请公布日期 2012.08.30
申请号 JP20120080895 申请日期 2012.03.30
申请人 PFIZER PRODUCTS INC 发明人 MORSEY MOHAMAD A;SHEPPARD MICHAEL GEORGE;WHEELER DAVID W
分类号 C12N15/09;A61K39/00;A61K39/39;A61K47/42;A61K48/00;A61P1/00;A61P1/04;A61P11/02;A61P11/06;A61P13/12;A61P27/02;A61P27/14;A61P37/02;A61P37/08;C07K14/47;C07K16/00;C07K16/18;C07K19/00;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12P21/02;G01N33/15 主分类号 C12N15/09
代理机构 代理人
主权项
地址